Literature DB >> 24740900

Human prion diseases and the risk of their transmission during anatomical dissection.

Barry M Bradford1, Pedro Piccardo, James W Ironside, Neil A Mabbott.   

Abstract

Prion diseases (or transmissible spongiform encephalopathies) are a unique group of fatal progressive neurodegenerative diseases of the central nervous system. The infectious agent is hypothesized to consist solely of a highly protease-resistant misfolded isoform of the host prion protein. Prions display a remarkable degree of resistance to chemical and physical decontamination. Many common forms of decontamination or neutralization used in infection control are ineffective against prions, except chaotropic agents that specifically disrupt proteins. Human cadaveric prosection or dissection for the purposes of teaching and demonstration of human anatomy has a distinguished history and remains one of the fundamentals of medical education. Iatrogenic transmission of human prion diseases has been demonstrated from the inoculation or implantation of human tissues. Therefore, although the incidence of human prion diseases is rare, restrictions exist upon the use of tissues from patients reported with dementia, specifically the brain and other central nervous system material. A current concern is the potential for asymptomatic variant Creutzfeldt-Jakob disease transmission within the UK population. Therefore, despite the preventative measures, the transmission of prion disease through human tissues remains a potential risk to those working with these materials. In this review, we aim to summarize the current knowledge on human prion disease relevant to those working with human tissues in the context of anatomical dissection.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  anatomical dissection; prion disease; risk of disease transmission; tissue distribution of prion infectivity; transmissible spongiform encephalopathy

Mesh:

Year:  2014        PMID: 24740900     DOI: 10.1002/ca.22403

Source DB:  PubMed          Journal:  Clin Anat        ISSN: 0897-3806            Impact factor:   2.414


  4 in total

Review 1.  Human prion diseases: surgical lessons learned from iatrogenic prion transmission.

Authors:  David J Bonda; Sunil Manjila; Prachi Mehndiratta; Fahd Khan; Benjamin R Miller; Kaine Onwuzulike; Gianfranco Puoti; Mark L Cohen; Lawrence B Schonberger; Ignazio Cali
Journal:  Neurosurg Focus       Date:  2016-07       Impact factor: 4.047

2.  Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993-2018.

Authors:  Peter Hermann; Johannes Treig; Steffen Unkel; Stefan Goebel; Timothy Bunck; Martha Jünemann; Tim Friede; Inga Zerr
Journal:  Emerg Infect Dis       Date:  2020-08       Impact factor: 6.883

3.  Prion disease diagnosis using subject-specific imaging biomarkers within a multi-kernel Gaussian process.

Authors:  Liane S Canas; Carole H Sudre; Enrico De Vita; Akin Nihat; Tze How Mok; Catherine F Slattery; Ross W Paterson; Alexander J M Foulkes; Harpreet Hyare; M Jorge Cardoso; John Thornton; Jonathan M Schott; Frederik Barkhof; John Collinge; Sébastien Ourselin; Simon Mead; Marc Modat
Journal:  Neuroimage Clin       Date:  2019-10-25       Impact factor: 4.881

Review 4.  The Effects of Immune System Modulation on Prion Disease Susceptibility and Pathogenesis.

Authors:  Neil A Mabbott; Barry M Bradford; Reiss Pal; Rachel Young; David S Donaldson
Journal:  Int J Mol Sci       Date:  2020-10-02       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.